Financials

  • Market Capitalization 2.38 B
  • Employee 370
  • Founded 2016
  • CEO N/A
  • Website www.tarsusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RB9BNQ7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-63.2
Relación precio/flujo de caja
5.56

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1875
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
9.45 USD-2.98%-11.27%+3.96%+8.00%2.40 B USD
1878
NRIX
Nurix Therapeutics, Inc. - Common stock
23.47 USD+2.13%-0.30%+38.63%+109.37%2.44 B USD
1887
VCEL
Vericel Corporation - Common Stock
47.28 USD+2.58%+1.63%+23.06%+30.07%2.41 B USD
1890
AGIO
Agios Pharmaceuticals, Inc. - Common Stock
39.75 USD-0.43%-7.49%+24.30%-8.39%2.36 B USD

Noticias